139 results on '"Saussez, Sven"'
Search Results
102. Antiproliferative effect of dexamethasone in the MCF-7 breast cancer cell line.
- Author
-
BUXANT, FREDERIC, KINDT, NADÈGE, LAURENT, GUY, NOËL, JEAN-CHRISTOPHE, and SAUSSEZ, SVEN
- Subjects
- *
BREAST cancer treatment , *DEXAMETHASONE , *CELL proliferation , *CELL lines , *GLUCOCORTICOID receptors , *APOPTOSIS , *IMMUNE response , *PREVENTION - Abstract
Glucocorticoids (GCs) are used in the treatment of cancer to induce programmed cell death in the transformed cells of the hematopoietic system and to reduce side effects. Additionally, GCs are described as an inhibitor of certain chemotherapy or radiation-induced apoptosis and also an inhibitor of cancer progression by downregulating or upregulating the expression of several genes. The present study used immunofluorescence to investigate the presence of the glucocorticoid receptor (GR) in MCF-7 cells, and the cell culture growth was determined by cell counting the number of cells following exposure to GC and/or dexamethasone (Dex). The presence and immunoreactivity of the GR were confirmed, and treatment with Dex (10-8-10-7 M) caused an inhibitory effect (30-35%) on the proliferative activity of the MCF-7 cells. This growth inhibitory effect was possibly produced by the pro-apopotic effect of Dex. Since Dex is administered systematically prior to breast cancer chemotherapy, the possible interactions between these drugs require further investigation. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
103. Contact allergy to benzalkonium chloride in patients using a steroid nasal spray: A report of 3 cases.
- Author
-
Lechien, Jérôme René, Costa de Araujo, Pedro, De Marrez, Lisa G., Halloy, Jean-Luc, Khalife, Mohamad, and Saussez, Sven
- Subjects
- *
AEROSOLS , *ANTI-infective agents , *CONTACT dermatitis , *DRUG allergy , *ITCHING , *NOSE , *RESPIRATORY obstructions , *RHINITIS , *SINUSITIS , *STEROIDS - Abstract
Benzalkonium chloride (BAC) is a bactericidal preservative excipient commonly found in steroid nasal sprays used to treat allergic rhinitis and nasal polyposis. In rare cases, BAC can be responsible for type I and type IV hypersensitivity reactions that can manifest as rhinorrhea, which a clinician might misinterpret as a lack of response to nasal spray therapy rather than a complication of it. We report 3 cases of type IV hypersensitivity reactions in patients who were being treated with mometasone nasal spray. We describe the epidemiology, clinical features, diagnosis, and treatment of these reactions. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
104. The Effects of Persistent Olfactory and Gustatory Dysfunctions on Quality of Life in Long-COVID-19 Patients.
- Author
-
Vaira, Luigi Angelo, Gessa, Claudia, Deiana, Giovanna, Salzano, Giovanni, Maglitto, Fabio, Lechien, Jerome R., Saussez, Sven, Piombino, Pasquale, Biglio, Andrea, Biglioli, Federico, Boscolo-Rizzo, Paolo, Hopkins, Claire, Parma, Valentina, and De Riu, Giacomo
- Subjects
- *
COVID-19 , *SMELL disorders , *QUALITY of life , *SYMPTOMS , *MYALGIA , *JOINT pain , *MENTAL fatigue - Abstract
(1) Background: Persistent olfactory (POD) and gustatory (PGD) dysfunctions are one of the most frequent symptoms of long-Coronavirus Disease 2019 but their effect on the quality of life (QoL) of patients is still largely unexplored. (2) Methods: An online survey was administered to individuals who reported to have had SARS-CoV-2 infection at least 6 months prior with persisting COVID-19 symptoms (using the COVID symptom index), including ratings of POD and PGD, and their physical (PCS) and mental (MCS) components of quality of life were assessed using the standardized short form 12 questionnaire (SF-12). (3) Results: Responses from 431 unique individuals were included in the analyses. The most frequent persistent symptoms were: fatigue (185 cases, 42.9%), olfactory dysfunction (127 cases, 29.5%), gustatory dysfunction (96 cases, 22.3%) and muscle pain (83 cases, 19.3%). Respondents who reported persisting muscle pain, joint pain, fatigue, headache, gastrointestinal disturbances, and dyspnea had significantly worse PCS. Those experiencing persistent fatigue and dyspnea also showed significantly lower MCS. Respondents reporting POD or PGD showed significantly worse QoL, but only pertaining to the MCS. Multiple regressions predicted MCS based on olfactory and marginally on gustatory ratings, but not PCS. Age significantly affected the prediction of PCS but not MCS, and gender and temporal distance from the COVID-19 diagnosis had no effect. (4) Conclusions: POD and PGD are frequent symptoms of the long-COVID-19 syndrome and significantly reduce QoL, specifically in the mental health component. This evidence should stimulate the establishment of appropriate infrastructure to support individuals with persistent CD, while research on effective therapies scales up. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
105. Helicase-like transcription factor: a new marker of well-differentiated thyroid cancers.
- Author
-
Arcolia, Vanessa, Paci, Paula, Dhont, Ludovic, Chantrain, Gilbert, Sirtaine, Nicolas, Decaestecker, Christine, Remmelink, Myriam, Belayew, Alexandra, and Saussez, Sven
- Subjects
- *
HELICASES , *TRANSCRIPTION factors , *BIOMARKERS , *PROTEIN expression ,THYROID cancer diagnosis - Abstract
Background: The preoperative characterization of thyroid nodules is a challenge for the clinicians. Fine-needle aspiration (FNA) is the commonly used pre-operative technique for diagnosis of malignant thyroid tumor. However, many benign lesions, with indeterminate diagnosis following FNA, are referred to surgery. There is an urgent need to identify biomarkers that could be used with the FNA to distinguish benign thyroid nodules from malignant tumors. The purpose of the study is to examine the level of expression of the helicase-like transcription factor (HLTF) in relation to neoplastic progression of thyroid carcinomas. Methods: The presence of HLTF was investigated using quantitative and semi-quantitative immunohistochemistry in a series of 149 thyroid lesion specimens. Our first clinical series was composed of 80 patients, including 20 patients presenting thyroid adenoma, 40 patients presenting thyroid papillary carcinoma, 12 patients presenting thyroid follicular carcinoma and 8 patients presenting anaplastic carcinoma. These specimens were assessed quantitatively using computer assisted microscopy. Our initial results were validated on a second clinical series composed of 40 benign thyroid lesions and 29 malignant thyroid lesions using a semi-quantitative approach. Finally, the HLTF protein expression was investigated by Western blotting in four thyroid cancer cell lines. Results: The decrease of HLTF staining was statistically significant during thyroid tumor progression in terms of both the percentage of mean optical density (MOD), which corresponds to the mean staining intensity (Kruskall-Wallis: p < 0.0005), and the labelling index (LI), which corresponds to the percentage of immunopositive cells (Kruskall-Wallis: p < 10-6). Adenomas presented very pronounced nuclear HLTF immunostaining, whereas papillary carcinomas exhibited HLTF only in the cytoplasm. The number of HLTF positive nuclei was clearly higher in the adenomas group (30%) than in the papillary carcinomas group (5%). The 115-kDa full size HLTF protein was immunodetected in four studied thyroid cancer cell lines. Moreover, three truncated HLTF forms (95-kDa, 80-kDa and 70-kDa) were also found in these tumor cells. Conclusions: This study reveals an association between HLTF expression level and thyroid neoplastic progression. Nuclear HLTF immunostaining could be used with FNA in an attempt to better distinguish benign thyroid nodules from malignant tumors. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
106. Helicase-like transcription factor: a new marker of well-differentiated thyroid cancers.
- Author
-
Arcolia, Vanessa, Paci, Paula, Dhont, Ludovic, Chantrain, Gilbert, Sirtaine, Nicolas, Decaestecker, Christine, Remmelink, Myriam, Belayew, Alexandra, and Saussez, Sven
- Abstract
Background: The preoperative characterization of thyroid nodules is a challenge for the clinicians. Fine-needle aspiration (FNA) is the commonly used pre-operative technique for diagnosis of malignant thyroid tumor. However, many benign lesions, with indeterminate diagnosis following FNA, are referred to surgery. There is an urgent need to identify biomarkers that could be used with the FNA to distinguish benign thyroid nodules from malignant tumors. The purpose of the study is to examine the level of expression of the helicase-like transcription factor (HLTF) in relation to neoplastic progression of thyroid carcinomas. Methods: The presence of HLTF was investigated using quantitative and semi-quantitative immunohistochemistry in a series of 149 thyroid lesion specimens. Our first clinical series was composed of 80 patients, including 20 patients presenting thyroid adenoma, 40 patients presenting thyroid papillary carcinoma, 12 patients presenting thyroid follicular carcinoma and 8 patients presenting anaplastic carcinoma. These specimens were assessed quantitatively using computer assisted microscopy. Our initial results were validated on a second clinical series composed of 40 benign thyroid lesions and 29 malignant thyroid lesions using a semi-quantitative approach. Finally, the HLTF protein expression was investigated by Western blotting in four thyroid cancer cell lines. Results: The decrease of HLTF staining was statistically significant during thyroid tumor progression in terms of both the percentage of mean optical density (MOD), which corresponds to the mean staining intensity (Kruskall-Wallis: p < 0.0005), and the labelling index (LI), which corresponds to the percentage of immunopositive cells (Kruskall-Wallis: p < 10−6). Adenomas presented very pronounced nuclear HLTF immunostaining, whereas papillary carcinomas exhibited HLTF only in the cytoplasm. The number of HLTF positive nuclei was clearly higher in the adenomas group (30%) than in the papillary carcinomas group (5%). The 115-kDa full size HLTF protein was immunodetected in four studied thyroid cancer cell lines. Moreover, three truncated HLTF forms (95-kDa, 80-kDa and 70-kDa) were also found in these tumor cells. Conclusions: This study reveals an association between HLTF expression level and thyroid neoplastic progression. Nuclear HLTF immunostaining could be used with FNA in an attempt to better distinguish benign thyroid nodules from malignant tumors. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
107. Involvement of CD74 in head and neck squamous cell carcinomas.
- Author
-
Kindt, Nadège, Lechien, Jérôme, Nonclercq, Denis, Laurent, Guy, and Saussez, Sven
- Subjects
- *
MACROPHAGE migration inhibitory factor , *CD antigens , *HEAD & neck cancer , *SQUAMOUS cell carcinoma , *INFLAMMATION , *CANCER invasiveness - Abstract
Purpose: While macrophage migration inhibitory factor (MIF) has been extensively studied in the context of inflammation and inflammatory disorders, less work has been devoted to its involvement in cancer, notably in neoplastic progression. In a previous study, we have found evidence that MIF plays a role in head and neck squamous cell carcinomas (HNSCC). The current investigations were undertaken in order to estimate the importance of the MIF receptor, CD74 in the progression of HNSCC. Methods and results: In a cohort of 46 cases of oral cavity carcinomas, immunohistochemical staining revealed an increase in CD74 expression during progression from benign lesions to carcinoma. As shown by cell culture experiments using squamous carcinoma cell line (SCCVII) transduced with anti-CD74 shRNA, the amount of cell-produced VEGF was lower in SCCVII CD74KD cell line compared with control SCCVII CD74sc cell line, suggesting that CD74 could be implicated in angiogenesis in vivo. Furthermore, knockdown of CD74 decreased proliferation of SCCVII cells in vitro. The migration of SCCVII cells, as well as the cell secretion of matrix metallopeptidase 9, was also negatively affected by CD74 knockdown. These observations in vitro were confirmed in an orthotopic mouse model of SCC where tumors produced by SCCVII CD74KD cell inoculation were found to grow more slowly than tumors generated by SCCVII CD74sc cells. Conclusion: The clinical observations and experimental data reported here suggest that CD74, as well as MIF, plays a pivotal role in HNSCC progression. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
108. Chronic Maxillary Rhinosinusitis of Dental Origin: A Systematic Review of 674 Patient Cases.
- Author
-
Lechien, Jerome R., Filleul, Olivier, de Araujo, Pedro Costa, Hsieh, Julien W., Chantrain, Gilbert, and Saussez, Sven
- Subjects
- *
SINUSITIS , *SYSTEMATIC reviews , *ETIOLOGY of diseases , *PERIODONTAL disease , *DENTAL therapeutics , *PATIENTS - Abstract
Objectives. The aim of this systematic review is to study the causes of odontogenic chronic maxillary rhinosinusitis (CMRS), the average age of the patients, the distribution by sex, and the teeth involved. Materials and Methods. We performed an EMBASE-, Cochrane-, and PubMed-based review of all of the described cases of odontogenic CMRS from January 1980 to January 2013. Issues of clinical relevance, such as the primary aetiology and the teeth involved, were evaluated for each case. Results. From the 190 identified publications, 23 were selected for a total of 674 patients following inclusion criteria. According to these data, the main cause of odontogenic CMRS is iatrogenic, accounting for 65.7% of the cases. Apical periodontal pathologies (apical granulomas, odontogenic cysts, and apical periodontitis) follow them and account for 25.1% of the cases. The most commonly involved teeth are the first and second molars. Conclusion. Odontogenic CMRS is a common disease that must be suspected whenever a patient undergoing dental treatment presents unilateral maxillary chronic rhinosinusitis. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
109. Laryngopharyngeal reflux after thyroidectomy.
- Author
-
Lechien, Jerome R., Verhasselt, Marie, Dequanter, Didier, Rodriguez, Alexandra, and Saussez, Sven
- Subjects
- *
LARYNGEAL nerve injuries , *THYROIDECTOMY , *VIDEOFLUOROSCOPY , *LARYNGEAL nerves , *ESOPHAGOGASTRIC junction - Published
- 2020
- Full Text
- View/download PDF
110. Anosmia Is a Key Symptom of COVID-19 Infection and Should Be Used as a Diagnostic Tool.
- Author
-
Lechien, Jerome R., Barillari, Maria Rosaria, Jouffe, Lionel, and Saussez, Sven
- Subjects
- *
EPITHELIAL cells , *SMELL disorders , *COVID-19 - Abstract
Based on observations described in our letter, we can draw the following conclusions: (1) anosmia must imperatively be added to the list of specific symptoms of COVID-19 infection, (2) anosmia can serve as a free and specific diagnostic tool for developing countries currently affected by the pandemic, (3) the mechanisms of COVID-19 anosmia seem not to directly involve nasal obstruction but rather seem to be related to damage the olfactory neuroepithelium. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
111. Parotitis-Like Symptoms Associated with COVID-19, France, March-April 2020.
- Author
-
Lechien, Jerome R., Chetrit, Annaelle, Chekkoury-Idrissi, Younes, Distinguin, Lea, Circiu, Marta, Saussez, Sven, Berradja, Najete, Edjlali, Myriam, Hans, Stephane, and Carlier, Robert
- Subjects
- *
COVID-19 , *SYMPTOMS , *SIALADENITIS , *MAGNETIC resonance imaging , *PAROTID gland diseases , *LYMPHADENITIS ,PAROTID gland tumors - Abstract
We report the clinical features of 3 patients in France who had parotitis (inflammation of the parotid salivary glands) as a clinical manifestation of confirmed coronavirus disease. Results from magnetic resonance imaging support the occurrence of intraparotid lymphadenitis, leading to a parotitis-like clinical picture. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
112. Gustatory dysfunctions in COVID-19.
- Author
-
Lechien, Jerome R., Hsieh, Julien W., Ayad, Tareck, Fakhry, Nicolas, Hans, Stephane, Chiesa-Estomba, Carlos M., and Saussez, Sven
- Subjects
- *
COVID-19 , *TASTE disorders , *RESPIRATORY infections - Abstract
Keywords: Smell; Taste; Anosmia; Hyposmia; Gustatory; Dysgeusia; Loss; COVID-19; Coronavirus; Dear editor EN Smell Taste Anosmia Hyposmia Gustatory Dysgeusia Loss COVID-19 Coronavirus Dear editor 2397 2398 2 07/07/20 20200801 NES 200801 Jerome R. Lechien and Julien W. Hsieh contributed to the paper and are joint as co-first authors. Dear Editor, We thank Dr Bigiani [[1]] for this letter entitled "Gustatory dysfunctions in COVID-19 patients: possible involvement of taste renin-angiotensin system (RAS)" which is related to our paper [[2]]. References 1 Bigiani A. Gustatory dysfunctions in COVID-19 patients: possible involvement of taste renin-angiotensin system (RAS). [Extracted from the article]
- Published
- 2020
- Full Text
- View/download PDF
113. Patient-Reported Outcome Questionnaires for the evaluation of olfactory and gustatory dysfunctions in COVID-19.
- Author
-
Lechien, Jerome R., Hsieh, Julien, Barillari, Maria Rosaria, Cammaroto, Giovanni, Hans, Stephane, Chiesa-Estomba, Carlos M., and Saussez, Sven
- Subjects
- *
COVID-19 , *TASTE disorders , *COVID-19 pandemic , *SARS-CoV-2 - Abstract
Keywords: Smell; Taste; Anosmia; Hyposmia; Loss; COVID-19; Coronavirus EN Smell Taste Anosmia Hyposmia Loss COVID-19 Coronavirus 2393 2394 2 07/07/20 20200801 NES 200801 Carlos M. Chiesa-Estomba and Sven Saussez equally contributed to the paper and are joint as co-senior authors. Although we acknowledge that large media coverage of these symptoms in the pandemic context may lead to overestimation of self-reported chemosensory loss, we are confident that we used a reliable patient-reported outcome questionnaire to assess the prevalence of self-reported olfactory and gustatory dysfunction during the COVID-19 pandemic. Smell, Taste, Anosmia, Hyposmia, Loss, COVID-19, Coronavirus. [Extracted from the article]
- Published
- 2020
- Full Text
- View/download PDF
114. Macrophage migration inhibitory factor in head and neck squamous cell carcinoma: clinical and experimental studies.
- Author
-
Kindt, Nadège, Preillon, Julie, Kaltner, Herbert, Gabius, Hans-Joachim, Chevalier, Dominique, Rodriguez, Alexandra, Johnson, Bryon, Megalizzi, Véronique, Decaestecker, Christine, Laurent, Guy, and Saussez, Sven
- Subjects
- *
MACROPHAGE migration inhibitory factor , *SQUAMOUS cell carcinoma , *HEAD & neck cancer , *CANCER invasiveness , *CANCER relapse , *ANTINEOPLASTIC agents , *METASTASIS - Abstract
Purpose: The present in vivo/in vitro study was undertaken in order to evaluate the importance of macrophage migration inhibitory factor (MIF) in the progression of head and neck squamous cell carcinoma (HNSCC). Methods: Tumor tissue expression (MIF immunostaining) and plasma levels (ELISA) of MIF were determined in HNSCC patients and correlated with tumor recurrence and metastasis, and overall survival. Furthermore, the impact of MIF expression on cell proliferation and anticancer drug sensitivity was examined in murine squamous carcinoma cell line SCCVII after MIF knockdown (MIF-KD). Results: As revealed by quantitative analysis of MIF immunostaining, tumor progression was accompanied by an increase in mean optical density (MOD) and labeling index (LI). Likewise, an elevation of MIF serum levels was noted in HNSCC patients ( n = 66) versus healthy individuals ( n = 16). Interestingly, comparison of laryngeal carcinoma patients on the basis of MIF tissue expression (high expression, LI ≥ 47, versus low expression, LI < 47) disclosed a significant difference between disease-free survival curves for local and nodal recurrence, and overall survival curve. In vitro, MIF knockdown in murine SCCVII cells resulted in reduced cell proliferation and a decrease in cell motility. In mice inoculated with SCCVII cells, MIF-KD tumors grew more slowly and also appeared more sensitive to chemotherapy. Conclusions: Both clinical observations and experimental data suggest that MIF plays a pivotal role in the progression of HNSCC. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
115. Expression of the helicase-like transcription factor and its variants during carcinogenesis of the uterine cervix: implications for tumour progression.
- Author
-
Capouillez, Aurélie, Noël, Jean-Christophe, Arafa, Mohammad, Arcolia, Vanessa, Mouallif, Mustapha, Guenin, Samuel, Delvenne, Philippe, Belayew, Alexandra, and Saussez, Sven
- Subjects
- *
LETTERS to the editor , *CERVICAL cancer research - Abstract
A letter to the editor is presented regarding a study on the immunohistochemical expression of helicase-like transcription factor (HLTF) at different stages of cervical carcinogenesis.
- Published
- 2011
- Full Text
- View/download PDF
116. Considering temozolomide as a novel potential treatment for esophageal cancer.
- Author
-
Bruyère, Céline, Lonez, Caroline, Duray, Anaelle, Cludts, Stéphanie, Ruysschaert, Jean-Marie, Saussez, Sven, Yeaton, Paul, Kiss, Robert, and Mijatovic, Tatjana
- Subjects
- *
CHEMOKINES , *ESOPHAGEAL cancer , *CANCER treatment , *CANCER cells , *XENOGRAFTS , *MICE - Abstract
BACKGROUND: C-X-C ligand (CXCL) chemokines exert major roles in the biologic aggressiveness of esophageal cancer. In the current study, the authors investigated temozolomide (TMZ)-induced effects on activity of the CXCL chemokine network in human esophageal cancer cells. To the authors' knowledge, TMZ has not been investigated previously in experimental or clinical esophageal cancers. METHODS: A complete mapping of CXCL chemokines and their receptor messenger RNA was performed in 2 established human esophageal cancer cell lines (OE21 and OE33) and in 4 surgical samples from patients with esophageal carcinoma. The analyses pointed out the potential importance of CXCL2, and monitoring CXCL2 with quantitative videomicroscopy indicated that its biologic activity was silenced in OE21 esophageal cancer cells. TMZ-mediated antitumor activity was determined in vivo in an OE21 metastatic nude mice xenograft model. RESULTS: The messenger RNA levels of CXC chemokines and their receptors were similar in both cell lines and in the 4 surgical specimens. CXCL2 depletion by small interfering RNA (siRNA) displayed marked effects on the proliferation of transfected OE21 cells. Chronic in vitro TMZ treatment of OE21 and OE33 cells markedly decreased CXCL2 and CXCL3 secretion. In vivo, TMZ induced significant delays in OE21 xenograft tumor development and improved the survival of OE21 xenograft-bearing mice, whereas cisplatin did not. Analyses performed on tissue samples from in vivo experiments revealed that TMZ also impaired tumor angiogenesis. CONCLUSIONS: The current study emphasized the role of proangiogenic chemokines in esophageal cancer biology and indicated the possibility of using TMZ as a clinically compatible drug to impair the actions of the CXCL chemokine network in esophageal cancers. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
117. Quantitative immunohistochemical fingerprinting of adhesion/growth-regulatory galectins in salivary gland tumours: divergent profiles with diagnostic potential.
- Author
-
Remmelink, Myriam, de Leval, Laurence, Decaestecker, Christine, Duray, Anaelle, Crompot, Emerence, Sirtaine, Nicolas, André, Sabine, Kaltner, Herbert, Leroy, Xavier, Gabius, Hans-Joachim, and Saussez, Sven
- Subjects
- *
DIAGNOSIS , *HUMAN fingerprints , *ADHESION , *IMMUNOHISTOCHEMISTRY , *SALIVARY glands - Abstract
Remmelink M, de Leval L, Decaestecker C, Duray A, Crompot E, Sirtaine N, André S, Kaltner H, Leroy X, Gabius H-J & Saussez S (2011) Histopathology 543-556 This study tests the hypothesis that histopathological fingerprinting of galectins, which are emerging multifunctional effectors in cell sociology, could refine the differential diagnosis of salivary tumours. We applied non-crossreactive polyclonal antibodies against galectin-1 (Gal-1), galectin-3 (Gal-3), galectin-7 (Gal-7) and galectin-8 (Gal-8) for immunohistochemical analysis of salivary gland tumours (72 cases with benign disease and 39 cases with malignancy) and 29 control specimens. The principal positivity of cases, the site of signal presence and the quantitative parameters concerning percentage of positive cells and labelling intensity were determined. Acinic cell and adenoid cystic carcinomas (specifically tubular and cribriform types) shared the expression signature of Gal-1, Gal-3 and Gal-8 presence combined with Gal-7 absence. Mucoepidermoid carcinomas presented a unique profile based on cytoplasmic Gal-1, Gal-3, Gal-7 and Gal-8 localization in the intermediate cells. Adenomas were separable from malignancy by a consistent decrease in the labelling index (LI) for Gal-7 and Gal-8 (LI Gal-7, P < 10; LI Gal-8, P = 0.001). When present, staining for the tumour suppressor p16 coincided with Gal-1 presence. Expression profiling of the four tested galectins in salivary gland tumours revealed non-uniform staining patterns with discriminatory potential based on intracellular localization and quantitative aspects. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
118. Combined analysis of HPV DNA, p16, p21 and p53 to predict prognosis in patients with stage IV hypopharyngeal carcinoma.
- Author
-
Ernoux-Neufcoeur, Perle, Arafa, Mohammad, Decaestecker, Christine, Duray, Anaëlle, Remmelink, Myriam, Leroy, Xavier, Herfs, Michael, Somja, Joan, Depuydt, Christophe, Delvenne, Philippe, and Saussez, Sven
- Subjects
- *
HYPOPHARYNX , *GENE expression , *CANCER diagnosis , *PAPILLOMAVIRUSES , *BIOMARKERS , *SQUAMOUS cell carcinoma , *IMMUNOHISTOCHEMISTRY , *POLYMERASE chain reaction , *TUMOR classification , *PROGNOSIS , *TUMORS - Abstract
Purpose: We examined p16, p21 and p53 expression in combination with the presence of human papillomavirus (HPV) DNA as molecular markers to predict survival in patients with stage IV hypopharyngeal squamous cell carcinoma (HSCC). Methods: Paraffin-embedded tumours from HSCC patients ( n = 75) were evaluated for p16, p21 and p53 expression by immunohistochemistry. HPV DNA was detected by GP5+/6+ consensus PCR and subsequent genotyping by E6/E7 type-specific PCR for HPV types 6, 11, 16, 18, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66 and 68. Results: Among the 61 specimens that tested positive for the β-globin, HPV typing identified 50 patients with high-risk (hr) HPV types. HPV 16E7 DNA was detected in 74% (37 cases) of these specimens. Twelve patients were found to be infected with multiple HPV types. However, the presence of hrHPV DNA was not found to correlate with the proportion of disease-free patients. The 5-year disease-free survival rate was 73% in p53− tumours versus 48% in p53+ tumours ( P = 0.008). Conclusion: In our series of patients with stage IV HSCC, the hrHPV+ subgroup had a similar prognosis (in terms of recurrence risk) as the HPV− subgroup. p53 overexpression was associated with a worse prognosis. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
119. In vivo assessment of temozolomide local delivery for lung cancer inhalation therapy
- Author
-
Wauthoz, Nathalie, Deleuze, Philippe, Hecq, Julien, Roland, Isabelle, Saussez, Sven, Adanja, Ivan, Debeir, Olivier, Decaestecker, Christine, Mathieu, Véronique, Kiss, Robert, and Amighi, Karim
- Subjects
- *
RESPIRATORY therapy , *DRUG delivery systems , *LUNG cancer treatment , *INTRAVENOUS injections , *MELANOMA , *BONE metastasis , *TRACHEA intubation , *CELL lines , *AEROSOL therapy - Abstract
Abstract: The aim of this study was to compare the efficacy of local drug delivery by inhalation to intravenous delivery in a B16F10 melanoma metastatic lung model. Temozolomide was formulated as a suspension, which was elaborated and evaluated in terms of particle size, shape and agglomeration. An endotracheal administration device was used to aerosolise the suspension. This mode of delivery was evaluated at different temozolomide concentrations and was optimized for the uniformity of delivered dose, the droplet size distribution and the distribution of droplets in vivo. Of the particles in the stabilised suspension, 79% were compatible with the human respirable size range, and this formulation retained 100% in vitro anticancer activity as compared to temozolomide alone in three distinct cancer cell lines. The pulmonary delivery device provided good reproducibility in terms of both the dose delivered and the droplet size distribution. Most of the lung tissues that were exposed to aerosol droplets contained the particles, as revealed by fluorescent microscopy techniques. The global in vivo antitumour activity of the inhaled temozolomide provided a median survival period similar to that for intravenous temozolomide delivery, and three out of 27 mice (11%) survived with almost complete eradication of the lung tumours. The present study thus shows that inhalation of a simple liquid formulation is well tolerated and active against a very biologically aggressive mouse melanoma pulmonary pseudo-metastatic model. This inhalation delivery could be used to deliver other types of anticancer drugs. [Copyright &y& Elsevier]
- Published
- 2010
- Full Text
- View/download PDF
120. Immune Suppression in Head and Neck Cancers: A Review.
- Author
-
Duray, Anaelle, Demoulin, Stephanie, Hubert, Pascale, Delvenne, Philippe, and Saussez, Sven
- Subjects
- *
SQUAMOUS cell carcinoma , *IMMUNOSUPPRESSION , *KILLER cells , *APOPTOSIS , *LANGERHANS cells - Abstract
Head and neck squamous cell carcinomas (HNSCCs) are the sixth most common cancer in the world. Despite significant advances in the treatment modalities involving surgery, radiotherapy, and concomitant chemoradiotherapy, the 5-year survival rate remained below 50% for the past 30 years. The worse prognosis of these cancers must certainly be link to the fact that HNSCCs strongly influence the host immune system. We present a critical review of our understanding of the HNSCC escape to the antitumor immune response such as a downregulation of HLA class I and/or components of APM. Antitumor responses of HNSCC patients are compromised in the presence of functional defects or apoptosis of T-cells, both circulating and tumorinfiltrating. Langerhans cells are increased in the first steps of the carcinogenesis but decreased in invasive carcinomas. The accumulation of macrophages in the peritumoral areas seems to play a protumoral role by secreting VEGF and stimulating the neoangiogenesis. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
121. The helicase-like transcription factor is a strong predictor of recurrence in hypopharyngeal but not in laryngeal squamous cell carcinomas.
- Author
-
Capouillez, Aurélie, Debauve, Gael, Decaestecker, Christine, Filleul, Olivier, Chevalier, Dominique, Mortuaire, Geoffrey, Coppée, Frederic, Leroy, Xavier, Belayew, Alexandra, and Saussez, Sven
- Subjects
- *
TRANSCRIPTION factors , *HELIX-loop-helix motifs , *PHARYNGEAL diseases , *SQUAMOUS cell carcinoma , *CANCER treatment , *BIOCHEMICAL genetics , *CLINICAL pathology , *THERAPEUTICS - Abstract
Aims: To examine the immunohistochemical expression of helicase-like transcription factor (HLTF) in relation to the prognosis of hypopharyngeal (HSCCs) and laryngeal (LSCCs) squamous cell carcinomas, and to characterize the HLTF protein variants expressed in biopsy specimens of head and neck squamous cell carcinoma (HNSCC) as well as the HeLa cell line. Methods and results: HLTF expression was determined by immunohistochemistry on a series of 100 hypopharyngeal (stage IV) and 56 laryngeal SCCs (stages I, II and IV). The HLTF variants were defined using reverse transcriptase-polymerase chain reaction and Western blots in 13 fresh HNSCC biopsies and in HeLa cells. High levels of HLTF expression were associated with rapid recurrence rates in a subgroup of 81 stage IV hypopharyngeal SCCs (with complete follow-up). A 95-kDa HLTF variant truncated at the carboxyl-terminal domain was detected in addition to the 115-kDa full-size protein in HNSCC biopsies, while six variants were observed in HeLa cells. Conclusions: Our results demonstrate, for the first time, that hypopharyngeal SCCs presenting high levels of HLTF have a worse prognosis. The quantitative determination of HLTF in hypopharyngeal SCCs was an independent prognostic marker alongside tumour node metastasis staging. HNSCCs expressed the truncated HLTF variant lacking the domains involved in DNA repair. [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
122. A 10-Year Follow-Up of a Randomized Prospective Study of 2 Treatments for Chronic Rhinosinusitis Without Nasal Polyps and Investigation of the Impact of Gastroeosophageal Reflux Disease in the Resistance to Treatment.
- Author
-
Lechien, Jerome R., Debie, Gersende, Mahillon, Virginie, Thill, Marie-Paule, Rodriguez, Alexandra, Horoi, Mihaela, Kampouridis, Stelianos, Muls, Vinciane, and Saussez, Sven
- Subjects
- *
PARANASAL sinus surgery , *NASAL polyps , *NATURAL immunity , *EVALUATION of medical care , *CLAVULANIC acid , *STEROIDS , *CLARITHROMYCIN , *GASTROESOPHAGEAL reflux , *TREATMENT failure , *COMPARATIVE studies , *DISEASE relapse , *SINUSITIS , *QUESTIONNAIRES , *DRUG side effects , *HELICOBACTER diseases , *AMOXICILLIN - Abstract
Objectives: To compare the 2 long-term medical strategies in chronic rhinosinusitis without nasal polyps (CRSnNP) and to identify the role of gastroesophageal reflux disease (GERD) and Helicobacter pylori as factors of treatment failure. Material and Methods: Fifty-seven patients with CRSnNP were randomized into 2 therapeutic groups. The first group was treated with 4 weeks of amoxicillin/clavulanate and a short course of oral steroids. The second group received 8 weeks of clarithromycin. Sinonasal Outcome Test-20 (SNOT-20) and Lund and Mackay scores were assessed at baseline and after treatment, and GERD Health-Related Quality of Life (GERD-HRQL) questionnaire was evaluated in all patients. Patients with a GERD-HRQL score >8 received esogastroscopy and H pylori detection. Patients were followed during a 10-year period for clinical course and GERD evolution. The 10-year evolution of patients was described in terms of recurrence, medical, and surgical treatments. Results: Thirty-seven patients completed the study; SNOT-20 and Lund and Mackay scores similarly improved in both groups. Amoxicillin/clavulanate group had significantly more adverse reactions than the clarithromycin group (P =.03). After the therapeutic course, 35% (amoxicillin/clavulanate) and 41% (clarithromycin) of patients needed functional endoscopic sinus surgery (FESS). During the long-term follow-up, 54% (amoxicillin/clavulanate) and 40% (clarithromycin) of patients had late CRSnNP recurrence; FESS was performed in less than 15% of cases of recurrence. Gastroesophageal reflux disease complaint's severity was associated with late recurrence of CRSnNP. Conclusion: Amoxicillin/clavulanate and clarithromycin would be competitive treatments for CRSnNP. Gastroesophageal reflux disease seems to be a negative factor for treatment response and recurrence. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
123. Correction to: Epidemiological, otolaryngological, olfactory and gustatory outcomes according to the severity of COVID-19: a study of 2579 patients.
- Author
-
Lechien, Jerome R., Chiesa-Estomba, Carlos M., Vaira, Luigi A., De Riu, Giacomo, Cammaroto, Giovanni, Chekkoury-Idrissi, Younes, Circiu, Marta, Distinguin, Lea, Journe, Fabrice, de Terwangne, Christophe, Machayekhi, Shahram, Barillari, Maria R., Calvo-Henriquez, Christian, Hans, Stéphane, and Saussez, Sven
- Subjects
- *
COVID-19 , *PATIENTS - Abstract
In the original publication of the article, one of the co-author's name was published incorrectly as "Liugi A. Varia". The correct name should read as "Luigi A. Vaira". [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
124. Correction to: Sinus and anterior skull base surgery during the COVID-19 pandemic: systematic review, synthesis and YO-IFOS position.
- Author
-
Radulesco, Thomas, Lechien, Jerome R., Sowerby, Leigh J., Saussez, Sven, Chiesa-Estomba, Carlos, Sargi, Zoukaa, Lavigne, Philippe, Calvo-Henriquez, Christian, Lim, Chwee Ming, Tangjaturonrasme, Napadon, Vatanasapt, Patravoot, Dehgani-Mobaraki, Puya, Fakhry, Nicolas, Ayad, Tareck, and Michel, Justin
- Subjects
- *
COVID-19 pandemic , *SKULL base , *SKULL surgery , *PERSONAL names , *ENDOSCOPIC surgery - Abstract
In the original publication of the article, one of the author's first and family name was published incorrectly. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
125. Atypical Clinical Presentation of Laryngopharyngeal Reflux: A 5-Year Case Series.
- Author
-
Lechien, Jerome R., Hans, Stéphane, Bobin, Francois, Calvo-Henriquez, Christian, Saussez, Sven, and Karkos, Petros D.
- Subjects
- *
BURNING mouth syndrome , *GASTROESOPHAGEAL reflux , *ACUTE otitis media , *ALIMENTARY canal , *DIGESTIVE enzymes , *VOCAL cords , *PROTON pump inhibitors - Abstract
Background: Laryngopharyngeal reflux (LPR) is a common disease in otolaryngology characterized by an inflammatory reaction of the mucosa of the upper aerodigestive tract caused by digestive refluxate enzymes. LPR has been identified as the etiological or favoring factor of laryngeal, oral, sinonasal, or otological diseases. In this case series, we reported the atypical clinical presentation of LPR in patients presenting in our clinic with reflux. Methods: A retrospective medical chart review of 351 patients with LPR treated in the European Reflux Clinic in Brussels, Poitiers and Paris was performed. In order to be included, patients had to report an atypical clinical presentation of LPR, consisting of symptoms or findings that are not described in the reflux symptom score and reflux sign assessment. The LPR diagnosis was confirmed with a 24 h hypopharyngeal-esophageal impedance pH study, and patients were treated with a combination of diet, proton pump inhibitors, and alginates. The atypical symptoms or findings had to be resolved from pre- to posttreatment. Results: From 2017 to 2021, 21 patients with atypical LPR were treated in our center. The clinical presentation consisted of recurrent aphthosis or burning mouth (N = 9), recurrent burps and abdominal disorders (N = 2), posterior nasal obstruction (N = 2), recurrent acute suppurative otitis media (N = 2), severe vocal fold dysplasia (N = 2), and recurrent acute rhinopharyngitis (N = 1), tearing (N = 1), aspirations (N = 1), or tracheobronchitis (N = 1). Abnormal upper aerodigestive tract reflux events were identified in all of these patients. Atypical clinical findings resolved and did not recur after an adequate antireflux treatment. Conclusion: LPR may present with various clinical presentations, including mouth, eye, tracheobronchial, nasal, or laryngeal findings, which may all regress with adequate treatment. Future studies are needed to better specify the relationship between LPR and these atypical findings through analyses identifying gastroduodenal enzymes in the inflamed tissue. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
126. New Treatment Strategy Targeting Galectin-1 against Thyroid Cancer.
- Author
-
Gheysen, Laetitia, Soumoy, Laura, Trelcat, Anne, Verset, Laurine, Journe, Fabrice, Saussez, Sven, and Poggi, Alessandro
- Subjects
- *
THYROID cancer , *ANAPLASTIC thyroid cancer , *CANCER cell motility , *CLINICAL drug trials , *OVERALL survival , *CELL migration inhibition , *THYROTROPIN receptors - Abstract
Although the overall survival rate of papillary or follicular thyroid cancers is good, anaplastic carcinomas and radio iodine refractory cancers remain a significant therapeutic challenge. Galectin-1 (Gal-1) is overexpressed in tumor cells and tumor-associated endothelial cells, and is broadly implicated in angiogenesis, cancer cell motility and invasion, and immune system escape. Our team has previously demonstrated a higher serum level of Gal-1 in patients with differentiated thyroid cancers versus healthy patients, and explored, by a knockdown strategy, the effect of Gal-1 silencing on cell proliferation and invasion in vitro, and on tumor and metastasis development in vivo. OTX008 is a calixarene derivative designed to bind the Gal-1 amphipathic β-sheet conformation and has previously demonstrated anti-proliferative and anti-invasive properties in several cancer cell lines including colon, breast, head and neck, and prostate cancer lines. In the current work, the impacts of OTX008 were evaluated in six thyroid cancer cell lines, and significant inhibitions of proliferation, migration, and invasion were observed in all lines expressing high Gal-1 levels. In addition, the signaling pathways affected by this drug were examined using RPPA (reverse phase protein array) and phosphoprotein expression assays, and opposite regulation of eNos, PYK2, and HSP27 by OTX008 was detected by comparing the two anaplastic lines 8505c and CAL 62. Finally, the sensitive 8505c line was xenografted in nude mice, and 3 weeks of OTX008 treatment (5 mg/kg/day) demonstrated a significant reduction in tumor and lung metastasize sizes without side effects. Overall, OXT008 showed significant anti-cancer effects both in vitro and in vivo in thyroid cancer lines expressing Gal-1, supporting further investigation of the molecular mechanisms of the drug and future clinical trials in patients with anaplastic thyroid cancer. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
127. Systematic review of international guidelines for tracheostomy in COVID-19 patients.
- Author
-
Chiesa-Estomba, Carlos M., Lechien, Jérome R., Calvo-Henríquez, Christian, Fakhry, Nicolas, Karkos, Petros D., Peer, Shazia, Sistiaga-Suarez, Jon A., Gónzalez-García, José A., Cammaroto, Giovanni, Mayo-Yánez, Miguel, Parente-Arias, Pablo, Saussez, Sven, and Ayad, Tareck
- Subjects
- *
COVID-19 , *TRACHEOTOMY , *OPERATIVE surgery , *META-analysis , *SARS-CoV-2 , *GUIDELINES , *PREVENTION of infectious disease transmission , *VIRAL pneumonia , *SERODIAGNOSIS , *SYSTEMATIC reviews , *SURGEONS , *MEDICAL protocols , *PSYCHOSOCIAL factors , *EPIDEMICS , *PATIENT-professional relations , *POLYMERASE chain reaction - Abstract
At this moment, the world lives under the SARS-CoV-2 outbreak pandemic. As Otolaryngologists - Head & Neck Surgeons, we need to perform and participate in examinations and procedures within the head and neck region and airway that carry a particularly high risk of exposure and infection because of aerosol and droplet contamination. One of those surgical procedures in demand at this moment is tracheostomy due the increasing ICU admissions. This review of international guidelines for tracheostomy in COVID-19 infected patients, aims to summarize in a systematic way the available recommendations: indications, timing, technique and safety measures for tracheostomy, from all over the world. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
128. Reflux and dental disorders in the pediatric population: A systematic review.
- Author
-
Lechien, Jerome R., CALVO-HENRIQUEZ, Christian, Chiesa-Estomba, Carlos M., Barillari, Maria Rosaria, Trozzi, Marilena, Meucci, Duino, Peer, Shazia, Ben Abdelouahed, Fairouz, Schindler, Antonio, and Saussez, Sven
- Subjects
- *
META-analysis , *TOOTH erosion , *SUBJECT headings , *GASTROESOPHAGEAL reflux , *DENTITION - Abstract
To investigate the role of laryngopharyngeal reflux (LPR) or gastroesophageal reflux disease (GERD) in the development of dental disorders in pediatric population. PubMed, Scopus Cochrane database were assessed for subject headings using the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-analyses) recommendations. Relevant studies published between January 1990 and January 2020 describing the association between reflux and dental disorders in children were retrieved. Three authors reviewed the LPR diagnosis method; inclusion criteria and outcomes. The bias analysis was performed through the tools of the Oxford Centre for Evidence-Based Medicine evidence levels. The electronic search identified 126 publications, of which 11 clinical studies and 2 basic science researches met our inclusion criteria. There is an important heterogeneity between studies about diagnostic method and clinical outcome evaluation. All studies based the reflux diagnosis on GERD criteria. No author considered hypopharyngeal nonacid reflux episodes through hypopharyngeal-esophageal intraluminal multichannel impedance pH monitoring (HEMII-pH). The results of studies support a higher prevalence of dental erosion in children with GERD compared with healthy individuals. Controversial findings were found about the potential association between reflux and caries, and the modification of both saliva composition and production in reflux children. The association between reflux and dental disorder is still uncertain. Future studies considering pharyngeal acid and nonacid reflux episodes through HEMII-pH are needed to confirm this hypothesis. The pepsin detection in saliva would be an additional way for detecting LPR in children with dental disorders. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
129. ACE2 Protein Landscape in the Head and Neck Region: The Conundrum of SARS-CoV-2 Infection.
- Author
-
Descamps, Géraldine, Verset, Laurine, Trelcat, Anne, Hopkins, Claire, Lechien, Jérome R., Journe, Fabrice, and Saussez, Sven
- Subjects
- *
SARS-CoV-2 , *RECEPTOR for advanced glycation end products (RAGE) , *COVID-19 pandemic , *MOUTH , *PARAFFIN wax , *ANGIOTENSIN converting enzyme , *NECK - Abstract
The coronavirus pandemic raging worldwide since December 2019 is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which invades human cells via the angiotensin-converting enzyme 2 (ACE2) receptor. Although it has already been identified in many organs, ACE2 expression remains largely unknown in the head and neck (HN) sphere. Thus, this study aims to investigate its protein expression in several sites of the upper aerodigestive tract in order to highlight potential routes of infection. We compared ACE2 immunohistochemical expression between 70 paraffin-embedded specimens with two different antibodies and reported the quantified expression in each histological location. Surprisingly, we obtained different results depending on the antibody, an absence of labeling having been observed with a monoclonal antibody raised against the extracellular domain, whereas the polyclonal, against the cytoplasmic part of the protein, revealed enriched ACE2 expression, particularly in sinuses, vocal cords, salivary glands and oral cavity epithelial cells. The interpretation of these discordant results has brought several exciting lines of reflection. In conclusion, this study provides possible routes of entry for the SARS-CoV-2 in HN region and, above all, has led us to encourage caution when studying the ACE2 expression which is currently at the center of all attention. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
130. Toad Venom Antiproliferative Activities on Metastatic Melanoma: Bio-Guided Fractionation and Screening of the Compounds of Two Different Venoms.
- Author
-
Soumoy, Laura, Wells, Mathilde, Najem, Ahmad, Krayem, Mohammad, Ghanem, Ghanem, Hambye, Stéphanie, Saussez, Sven, Blankert, Bertrand, and Journe, Fabrice
- Subjects
- *
DACARBAZINE , *VENOM , *CARDIAC glycosides , *MELANOMA , *TOADS , *CANCER patients - Abstract
Melanoma is the most common cancer in young adults, with a constantly increasing incidence. Metastatic melanoma is a very aggressive cancer with a 5-year survival rate of about 22−25%. This is, in most cases, due to a lack of therapies which are effective on the long term. Hence, it is crucial to find new therapeutic agents to increase patient survival. Toad venoms are a rich source of potentially pharmaceutically active compounds and studies have highlighted their possible effect on cancer cells. We focused on the venoms of two different toad species: Bufo bufo and Rhinella marina. We screened the venom crude extracts, the fractions from crude extracts and isolated biomolecules by studying their antiproliferative properties on melanoma cells aiming to determine the compound or the combination of compounds with the highest antiproliferative effect. Our results indicated strong antiproliferative capacities of toad venoms on melanoma cells. We found that these effects were mainly due to bufadienolides that are cardiotonic steroids potentially acting on the Na+/K+ ATPase pump which is overexpressed in melanoma. Finally, our results indicated that bufalin alone was the most interesting compound among the isolated bufadienolides because it had the highest antiproliferative activity on melanoma cells. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
131. Metabolic Reprogramming in Metastatic Melanoma with Acquired Resistance to Targeted Therapies: Integrative Metabolomic and Proteomic Analysis.
- Author
-
Soumoy, Laura, Schepkens, Corentin, Krayem, Mohammad, Najem, Ahmad, Tagliatti, Vanessa, Ghanem, Ghanem E., Saussez, Sven, Colet, Jean-Marie, and Journe, Fabrice
- Subjects
- *
BASAL metabolism , *CELL lines , *CELLULAR signal transduction , *DRUG resistance in cancer cells , *MELANOMA , *METASTASIS , *ONCOGENES , *TRANSFERASES , *PROTEOMICS , *PROTEIN microarrays , *METABOLOMICS , *METABOLISM - Abstract
Treatments of metastatic melanoma underwent an impressive development over the past few years, with the emergence of small molecule inhibitors targeting mutated proteins, such as BRAF, NRAS, or cKIT. However, since a significant proportion of patients acquire resistance to these therapies, new strategies are currently being considered to overcome this issue. For this purpose, melanoma cell lines with mutant BRAF, NRAS, or cKIT and with acquired resistances to BRAF, MEK, or cKIT inhibitors, respectively, were investigated using both 1H-NMR-based metabonomic and protein microarrays. The 1H-NMR profiles highlighted a similar go and return pattern in the metabolism of the BRAF, NRAS, and cKIT mutated cell lines. Indeed, melanoma cells exposed to mutation-specific inhibitors underwent metabolic disruptions following acute exposure but partially recovered their basal metabolism in long-term exposure, most likely acquiring resistance skills. The protein microarrays inquired about the potential cellular mechanisms used by the resistant cells to escape drug treatment, by showing decreased levels of proteins linked to the drug efficacy, especially in the downstream part of the MAPK signaling pathway. Integrating metabonomic and proteomic findings revealed some metabolic pathways (i.e., glutaminolysis, choline metabolism, glutathione production, glycolysis, oxidative phosphorylation) and key proteins (i.e., EPHA2, DUSP4, and HIF-1A) as potential targets to discard drug resistance. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
132. HPV Involvement in the Tumor Microenvironment and Immune Treatment in Head and Neck Squamous Cell Carcinomas.
- Author
-
Lechien, Jérôme R., Descamps, Géraldine, Seminerio, Imelda, Furgiuele, Sonia, Dequanter, Didier, Mouawad, Francois, Badoual, Cécile, Journe, Fabrice, and Saussez, Sven
- Subjects
- *
HEAD tumors , *IMMUNITY , *NECK tumors , *PAPILLOMAVIRUSES , *SQUAMOUS cell carcinoma - Abstract
Head and neck squamous cell carcinomas (HNSCC) are one of the most prevalent cancers worldwide. Active human papillomavirus (HPV) infection has been identified as an important additional risk factor and seems to be associated with a better prognosis in non-drinker and non-smoker young patients with oropharyngeal SCC. The better response of the immune system against the HPV-induced HNSCC is suspected as a potential explanation for the better prognosis of young patients. To further assess this hypothesis, our review aims to shed light the current knowledge about the impact of HPV infection on the immune response in the context of HNSCC, focusing on the innate immune system, particularly highlighting the role of macrophages, Langerhans and myeloid cells, and on the adaptative immune system, pointing out the involvement of T regulatory, T CD8 and T CD4 lymphocytes. In addition, we also review the preventive (HPV vaccines) and therapeutic (checkpoint inhibitors) strategies against HPV-related HNSCC, stressing the use of anti-CTLA4, PD-L1, PD-L2 antibodies alone and in combination with other agents able to modulate immune responses. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
133. Molecular Imaging of Galectin-1 Expression as a Biomarker of Papillary Thyroid Cancer by Using Peptide-Functionalized Imaging Probes.
- Author
-
Fanfone, Deborah, Stanicki, Dimitri, Nonclercq, Denis, Port, Marc, Vander Elst, Luce, Laurent, Sophie, Muller, Robert N., Saussez, Sven, and Burtea, Carmen
- Abstract
Thyroid cancers are the most frequent endocrine cancers and their incidence is increasing worldwide. Thyroid nodules occur in over 19–68% of the population, but only 7–15% of them are diagnosed as malignant. Diagnosis relies on a fine needle aspiration biopsy, which is often inconclusive and about 90% of thyroidectomies are performed for benign lesions. Galectin-1 has been proposed as a confident biomarker for the discrimination of malignant from benign nodules. We previously identified by phage display two peptides (P1 and P7) targeting galectin-1, with the goal of developing imaging probes for non-invasive diagnosis of thyroid cancer. The peptides were coupled to ultra-small superparamagnetic particles of iron oxide (USPIO) or to a near-infrared dye (CF770) for non-invasive detection of galectin-1 expression in a mouse model of papillary thyroid cancer (PTC, as the most frequent one) by magnetic resonance imaging and fluorescence lifetime imaging. The imaging probes functionalized with the two peptides presented comparable image enhancement characteristics. However, those coupled to P7 were more favorable, and showed decreased retention by the liver and spleen (known for their galectin-1 expression) and high sensitivity (75%) and specificity (100%) of PTC detection, which confirm the aptitude of this peptide to discriminate human malignant from benign nodules (80% sensitivity, 100% specificity) previously observed by immunohistochemistry. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
134. Impact of HPV Infection on the Immune System in Oropharyngeal and Non-Oropharyngeal Squamous Cell Carcinoma: A Systematic Review.
- Author
-
Lechien, Jerome R., Seminerio, Imelda, Descamps, Géraldine, Mat, Quentin, Mouawad, Francois, Hans, Stéphane, Julieron, Morbize, Dequanter, Didier, Vanderhaegen, Thibault, Journe, Fabrice, and Saussez, Sven
- Subjects
- *
SQUAMOUS cell carcinoma , *IMMUNE system , *SUPPRESSOR cells , *META-analysis , *PAPILLOMAVIRUSES , *INTRA-aortic balloon counterpulsation - Abstract
Objectives: To review the current knowledge regarding the involvement of human papilloma virus (HPV) infection and the immune system in the development of head and neck squamous cell carcinoma (HNSCC). Methods: An electronic literature search was conducted to identify articles published between 1990 and 2019 pertaining to tumor-infiltrating immune cells (TICs) in HNSCC using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Issues of clinical relevance, including tumor location, the number of tumor samples, the inclusion of additional specimens (dysplastic or normal mucosa), tumor size, methods used for HPV detection, relationship between antigen expression and patient characteristics (age, gender, smoking, alcohol consumption, etc.), and prognostic data (overall survival (OS) and recurrence-free survival (RFS)) were assessed by four blinded investigators. Results: The search identified 335 relevant studies, of which 41 met the inclusion criteria. Of these, 7 studies focused on the peripheral blood immune cell concentration in patients with HNSCC according to HPV status, and 36 studies investigated TICs in the intraepithelial and/or stromal compartment(s) according to HPV status. The immune cells studied were CD8+ T cells (N = 19), CD4+ T cells (N = 7), regulatory T cells (Tregs, N = 15), macrophages (N = 13), myeloid-derived suppressor cells (MDSCs, N = 4), and Langerhans cells (LCs, N = 2). Conclusions: Irrespective of tumor location, CD8+ and CD4+ T cells appear to play a key role in the development of HPV−related HNSCC, and their infiltration is likely associated with a significant impact on OS and RFS. To date, the roles and prognostic value of Tregs, macrophages, DCs and MDSCs remain unclear. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
135. Cover Image.
- Author
-
Lechien, Jérôme R., Huet, Kathy, Khalife, Mohamad, De Marrez, Lisa G., Finck, Camille, Harmegnies, Bernard, and Saussez, Sven
- Subjects
- *
LOW-fat diet , *IMAGE - Published
- 2019
- Full Text
- View/download PDF
136. Role of Macrophage Migration Inhibitory Factor (MIF) in Melanoma.
- Author
-
Soumoy, Laura, Kindt, Nadège, Ghanem, Ghanem, Saussez, Sven, and Journe, Fabrice
- Subjects
- *
CELL migration , *CELLULAR signal transduction , *COMBINED modality therapy , *IMMUNITY , *LYMPHOKINES , *MACROPHAGES , *MELANOMA , *METASTASIS , *MICROBIOLOGICAL assay , *GENETIC mutation , *NEOVASCULARIZATION , *OXIDOREDUCTASES - Abstract
Macrophage migration inhibitory factor (MIF) is an inflammatory cytokine involved in the carcinogenesis of many cancer types. Here, we review the published experimental and clinical data for MIF and its involvement in melanoma. All reported data show that MIF is overexpressed in melanoma cells, especially in case of metastatic disease. Clinical studies also indicate that high MIF expression is positively associated with aggressiveness of the disease. Some data also highlight the implication of MIF in angiogenesis, immunity and metastasis in melanoma cell lines, as well as the availability of different therapeutic options targeting MIF for the treatment of metastatic melanoma. Indeed, the main problem in metastatic melanoma is the lack of long-term effective treatment. This is linked to the capacity of melanoma cells to mutate very quickly and/or activate alternative signaling pathways. Thus, MIF targeting therapies could provide a new effective way of treating melanoma. Moreover, cell sensitivity to MIF depletion does not correlate with the BRAF mutational status. Regarding the fact that many melanoma patients carry a BRAF mutation, and that they develop resistance to BRAF inhibitors, this observation is very interesting as MIF inhibitors could be used to treat many patients in relapse after treatment with an inhibitor of the mutant BRAF protein. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
137. Infiltration of FoxP3+ Regulatory T Cells is a Strong and Independent Prognostic Factor in Head and Neck Squamous Cell Carcinoma.
- Author
-
Seminerio, Imelda, Descamps, Géraldine, Dupont, Sophie, de Marrez, Lisa, Laigle, Jean-Alexandre, Lechien, Jérôme R, Kindt, Nadège, Journe, Fabrice, and Saussez, Sven
- Subjects
- *
SQUAMOUS cell carcinoma , *HEAD & neck cancer , *T cells , *MULTIVARIATE analysis , *PAPILLOMAVIRUS diseases , *SURVIVAL , *TUMOR classification , *PROGNOSIS , *PHYSIOLOGY - Abstract
Head and Neck Squamous Cell Carcinomas (HNSCC) are characterized by a large heterogeneity in terms of the location and risk factors. For a few years now, immunotherapy seems to be a promising approach in the treatment of these cancers, but a better understanding of the immune context could allow to offer a personalized treatment and thus probably increase the survival of HNSCC patients. In this context, we evaluated the infiltration of FoxP3+ Tregs on 205 human formalin-fixed paraffin-embedded HNSCC and we assessed its prognostic value compared to other potential prognostic factors, including HPV infection. First, we found a positive correlation of FoxP3+ Treg infiltration between the intra-tumoral (IT) and the stromal (ST) compartments of the tumors (p < 0.0001). A high infiltration of these cells in both compartments was associated with longer recurrence-free (ST, RFS, p = 0.007; IT, RFS, p = 0.019) and overall survivals (ST, OS, p = 0.002; ST, OS, p = 0.002) of HNSCC patients. Early tumor stage (OS, p = 0.002) and differentiated tumors (RFS, p = 0.022; OS, p = 0.043) were also associated with favorable prognoses. Multivariate analysis revealed that FoxP3+ Treg stromal infiltration, tumor stage and histological grade independently influenced patient prognosis. In conclusion, the combination of these three markers seem to be an interesting prognostic signature for HNSCC. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
138. Involvement of HPV Infection in the Release of Macrophage Migration Inhibitory Factor in Head and Neck Squamous Cell Carcinoma.
- Author
-
Kindt, Nadège, Descamps, Géraldine, Lechien, Jérôme R., Remmelink, Myriam, Colet, Jean-Marie, Wattiez, Ruddy, Berchem, Guy, Journe, Fabrice, and Saussez, Sven
- Subjects
- *
MACROPHAGE migration inhibitory factor , *SQUAMOUS cell carcinoma , *PAPILLOMAVIRUSES , *LACTATES , *NUCLEAR magnetic resonance , *PROTON magnetic resonance - Abstract
Human papilloma virus (HPV) infection has been well-established as a risk factor in head and neck squamous cell carcinoma (HNSCC). The carcinogenic effect of HPV is mainly due to the E6 and E7 oncoproteins, which inhibit the functions of p53 and pRB, respectively. These oncoproteins could also play a role in the Warburg effect, thus favoring tumor immune escape. Here, we demonstrated that the pro-inflammatory cytokine macrophage migration inhibitory factor (MIF) is expressed at higher levels in HPV-negative patients than in HPV-positive patients. However, the secretion of MIF is higher in HPV-positive human HNSCC cell lines, than in HPV-negative cell lines. In-HPV positive cells, the half inhibitory concentration (IC50) of MIF inhibitor (4-iodo-6-phenylpyrimidine (4-IPP)) is higher than that in HPV-negative cells. This result was confirmed in vitro and in vivo by the use of murine SCCVII cell lines expressing either E6 or E7, or both E6 and E7. Finally, to examine the mechanism of MIF secretion, we conducted proton nuclear magnetic resonance (1H-NMR) experiments, and observed that lactate production is increased in both the intracellular and conditioned media of HPV-positive cells. In conclusion, our data suggest that the stimulation of enzymes participating in the Warburg effect by E6 and E7 oncoproteins increases lactate production and hypoxia inducible factor 1α (HIF-1α) expression, and finally induces MIF secretion. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
139. Helicase-like transcription factor: a new marker of well-differentiated thyroid cancers.
- Author
-
Arcolia, Vanessa, Paci, Paula, Dhont, Ludovic, Chantrain, Gilbert, Sirtaine, Nicolas, Decaestecker, Christine, Remmelink, Myriam, Belayew, Alexandra, and Saussez, Sven
- Abstract
Background: The preoperative characterization of thyroid nodules is a challenge for the clinicians. Fine-needle aspiration (FNA) is the commonly used pre-operative technique for diagnosis of malignant thyroid tumor. However, many benign lesions, with indeterminate diagnosis following FNA, are referred to surgery. There is an urgent need to identify biomarkers that could be used with the FNA to distinguish benign thyroid nodules from malignant tumors. The purpose of the study is to examine the level of expression of the helicase-like transcription factor (HLTF) in relation to neoplastic progression of thyroid carcinomas.Methods: The presence of HLTF was investigated using quantitative and semi-quantitative immunohistochemistry in a series of 149 thyroid lesion specimens. Our first clinical series was composed of 80 patients, including 20 patients presenting thyroid adenoma, 40 patients presenting thyroid papillary carcinoma, 12 patients presenting thyroid follicular carcinoma and 8 patients presenting anaplastic carcinoma. These specimens were assessed quantitatively using computer assisted microscopy. Our initial results were validated on a second clinical series composed of 40 benign thyroid lesions and 29 malignant thyroid lesions using a semi-quantitative approach. Finally, the HLTF protein expression was investigated by Western blotting in four thyroid cancer cell lines.Results: The decrease of HLTF staining was statistically significant during thyroid tumor progression in terms of both the percentage of mean optical density (MOD), which corresponds to the mean staining intensity (Kruskall-Wallis: p < 0.0005), and the labelling index (LI), which corresponds to the percentage of immunopositive cells (Kruskall-Wallis: p < 10-6). Adenomas presented very pronounced nuclear HLTF immunostaining, whereas papillary carcinomas exhibited HLTF only in the cytoplasm. The number of HLTF positive nuclei was clearly higher in the adenomas group (30%) than in the papillary carcinomas group (5%).The 115-kDa full size HLTF protein was immunodetected in four studied thyroid cancer cell lines. Moreover, three truncated HLTF forms (95-kDa, 80-kDa and 70-kDa) were also found in these tumor cells.Conclusions: This study reveals an association between HLTF expression level and thyroid neoplastic progression. Nuclear HLTF immunostaining could be used with FNA in an attempt to better distinguish benign thyroid nodules from malignant tumors. [ABSTRACT FROM AUTHOR]- Published
- 2014
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.